Key facts
- This page summarizes Mark Fawcett's Form 4 filing for Clinigence Holdings, Inc. (NUTX).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 21 Dec 2021, 12:26.
Mark Fawcett - 25 Feb 2021 Form 4 Insider Report for Clinigence Holdings, Inc. (NUTX)
- Reporting relationship
- Director
- Issuer ticker
- NUTX
- Reported as of
- 25 Feb 2021
- Net transaction value
- +$571,255
- SEC form
- 4
- Accepted by SEC
- 21 Dec 2021, 12:26:48 UTC
- Next SEC filing
- 24 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- Mark Fawcett
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Mark Fawcett filed Form 4 for Clinigence Holdings, Inc. (NUTX) on 21 Dec 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: +$571,255.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NUTX
transaction
Common Stock
Other
- Transaction value
- $547,257
- Shares
- +268,263
- Change %
- +2982%
- Price
- $2.04*
- Shares after
- 277,259
- Date
- 28 Jan 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NUTX
transaction
Derivative
Director Stock Option (right to buy)
Purchase
- Transaction value
- Shares
- +85,120
- Change %
- Price
- Shares after
- 85,120
- Date
- 05 Aug 2020
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 85,120
- Exercise price
- Footnotes
- F2
NUTX
transaction
Derivative
Warrants to Puchase common stock
Purchase
- Transaction value
- $23,999
- Shares
- +3,598
- Change %
- Price
- $6.67*
- Shares after
- 3,598
- Date
- 21 Mar 2019
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,598
- Exercise price
- $6.67
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Acquired as per Merger Transaction exchange
Footnote F2
10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024